Previous 10 | Next 10 |
2023-04-13 08:28:20 ET GlucoTrack ( GCTK ) -36% after plans for common stock offering. Scilex Holding Company ( SCLX ) -20% . HeartCore Enterprises ( HTCR ) -20% . Sportsman's Warehouse Holdings ( SPWH ) -20% after Q4 earning release. ...
2023-04-13 07:54:33 ET Sarepta Therapeutics ( NASDAQ: SRPT ) lost ~11% pre-market Thursday after a Stat News report indicated that certain FDA staff members had initially opposed the company's gene therapy candidate SRP-9001 before the agency eventually agreed to hold an A...
2023-04-13 01:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-04-12 15:36:24 ET Summary The Avidity Biosciences, Inc. final results from phase 1/2 EXPLORE44 study using AOC 1044 for the treatment of patients with Duchenne Muscular Dystrophy expected in the 2nd half of 2023. It is said that the global Duchenne Muscular Dystrophy market i...
2023-04-10 15:36:01 ET Deutsche Bank raised its recommendation for contract manufacturer Catalent ( NYSE: CTLT ) to Buy from Hold and lifted its price target to $88 from $79 per share, citing a potential upside to the company's 2023/ 2024 estimates. "The crux of our upgrade is t...
2023-04-10 12:20:08 ET Sarepta Therapeutics ( NASDAQ: SRPT ) announced Monday that the FDA would hold an advisory committee meeting on May 12, 2023, to evaluate its marketing application for gene therapy SRP-9001, targeted at Duchenne muscular dystrophy. Sarepta ( SRPT ) s...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that the date of the U.S. Food and Drug Administration’s Cellular, Tissue and Gene Therapies Advisory Committee meeting for the SRP-9001 (delandistrogene moxeparvovec) biol...
2023-04-06 05:39:00 ET If you're looking for stocks that can make big moves in a short amount of time, the biotech industry has you covered. There are some drugmaker stocks out there that could shoot higher or tumble lower this spring. Developing useful new drugs can be an extremely luc...
2023-04-04 11:57:51 ET Barclays downgraded the contract manufacturer Catalent ( NYSE: CTLT ), citing a balanced upside/downside setup based on what the firm pointed to as seemingly "aggressive" implied Q4 FY23 estimates and a lack of clarity in the FY24 outlook. While arguing th...
2023-04-04 08:12:59 ET Sarepta Therapeutics ( NASDAQ: SRPT ) shares trended higher in the pre-market Tuesday after Citi initiated its coverage with a Buy recommendation citing a compelling setup ahead of an FDA advisory committee meeting scheduled for its gene therapy candidate SRP-...
News, Short Squeeze, Breakout and More Instantly...
Sarepta Therapeutics Inc. Company Name:
SRPT Stock Symbol:
NASDAQ Market:
Sarepta Therapeutics Inc. Website:
Rick Barry appointed Executive Chairman of the Board Remi Barbier resigns as President and CEO and from the Board of Directors Cassava initiates search for a new CEO AUSTIN, Texas, July 17, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA) today announced that the Boa...
2024-07-08 12:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...